Corresponding Author

Barbara Rivera

Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain

Gerald Bronfman Department of Oncology, McGill University Montreal, Canada

Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada

Correspondence Barbara Rivera Polo PhD, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), IDIBELL, Avinguda de la Granvia de l’Hospitalet, 199, 08908, L’Hospitalet de Llobregat, Barcelona, España.

Email: brivera@idibell.cat